Reply to Bernstein, Atmar, and Hoft

Affiliations

¹ LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Comment

Alison Han et al. Clin Infect Dis. 2020.

. 2020 Dec 31;71(11):3013-3014.

doi: 10.1093/cid/ciaa279.

¹ LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

No abstract available

Comment on

A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
Han A, Czajkowski LM, Donaldson A, Baus HA, Reed SM, Athota RS, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ. Han A, et al. Clin Infect Dis. 2019 Nov 27;69(12):2082-2090. doi: 10.1093/cid/ciz141. Clin Infect Dis. 2019. PMID: 30770534 Free PMC article.
Influenza Challenge Models: Ready for Prime Time?
Bernstein DI, Atmar RL, Hoft DF. Bernstein DI, et al. Clin Infect Dis. 2020 Dec 31;71(11):3012-3013. doi: 10.1093/cid/ciaa278. Clin Infect Dis. 2020. PMID: 32206804 Free PMC article. No abstract available.

1. Han A, Czajkowski LM, Donaldson A, et al. A Dose-finding study of a wild-type influenza A(H3N2) virus in a healthy volunteer human challenge model. Clin Infect Dis 2019; 69:2082–90. - PMC - PubMed
1. Memoli MJ, Czajkowski L, Reed S, et al. Validation of the wild-type influenza a human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. Clin Infect Dis 2015; 60:693–702. - PMC - PubMed
1. Memoli MJ, Shaw PA, Han A, et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. mBio 2016; 7:e00417–16. - PMC - PubMed
1. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775–85. - PubMed
1. Ridgway JP, Bartlett AH, Garcia-Houchins S, et al. Influenza among afebrile and vaccinated healthcare workers. Clin Infect Dis 2015; 60:1591–5. - PMC - PubMed